title: Significantly lower relapse rate for TEL/AML1-positive ALL.
authors.forename: J
authors.initials: J
authors.lastname: Zuna
authors.forename: O
authors.initials: O
authors.lastname: Hrusák
authors.forename: M
authors.initials: M
authors.lastname: Kalinová
authors.forename: K
authors.initials: K
authors.lastname: Muzíková
authors.forename: J
authors.initials: J
authors.lastname: Starý
authors.forename: J
authors.initials: J
authors.lastname: Trka
mesh_terms: D019677:Artificial Gene Fusion; D002051:Burkitt Lymphoma / Q000453:epidemiology / Q000235:genetics*; D003604:Czechoslovakia / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D009363:Neoplasm Proteins / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000235:genetics*; D012008:Recurrence; D014178:Translocation, Genetic
chemical_list: D009363:Neoplasm Proteins